FDA Investigator LCDR Margaret Edi Gennaro
LCDR Margaret Edi Gennaro has conducted inspections on 178 sites in 2 countries as of 06 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
178
Last Inspection Date:
06 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Canada
FDA Investigators that have inspected at least one site in common with LCDR Margaret Edi Gennaro:
Abdellah El Hajjam,
Alan D Centi,
Alla Kachko, PhD,
Amanda B Athey,
Amanda B Vega,
Amy A Johnson,
Anastasia I Offordile,
Anastasia I Onuorah,
Andrew J Howard,
Angela L Hatzenbuhler,
Anissa M Cheung,
Anita R Michael,
Ann L Demarco,
Ann Marie Karnick,
Ann Marie Montemurro,
Ann Marie Schofield,
Audrey Thereset Uy,
Austin B Appler,
Brandi L Garbutt,
Brandon J Brookens,
Brentley S Collins,
Brian D Young,
Brian M Palermo,
Brian S Keefer,
Calvin W Edwards,
Cara M Minelli,
Carl E Lovrich,
Carrie L Doupnik,
CDR Jeremy L Wally, PhD,
CDR Michael J Mero,
Chamberlain,
Chao Ming Tsai,
Christian D Lynch (CDL),
Christina J Sauder, PhD,
Christina K Theodorou,
Christopher J Adams,
Colleen M Damon,
Craig D Zagata,
Crayton Lee,
Crystal A Harlan,
Cynthia A Palmer,
Cynthia F Kleppinger, MD,
Cynthia Jim, CSO,
Cynthia L Rakestraw,
Cynthia White,
Daniel J Deciero,
Daniel J Mechenbier,
Daniel J Min,
Daniel R Tammariello,
Daniel T Lee,
Daniel W Johnson,
Dauksism,
Dave Hafner,
David A Oluwo,
David J Hafner,
David L Pearce,
Dawn D Aiello,
Deborah G Haney Cozzone,
Deborah J Parris,
Debra J Bennett,
Debra L Pagano,
Dennis R Hock,
Dr. Mark J Seaton, PhD,
Edwin L Hobbs,
Eileen A Liu,
Ellen Huang,
Eric S Myskowski,
Erica L Nicoll,
Erika M Wilkerson,
Erin M Holliman,
Estefania Fernandez,
Ethan P Stegman,
Gabrielle J Swain,
Gayle S Lawson,
Gene D Arcy,
Gerald W Kopp,
Gregory E Beichner,
Hala L Selby,
Haruhiko Murata,
Helen B Ricalde,
Iqra Iftikhar,
J David Doleski,
Jacob M Dyer,
Jacqueline Mdiaz Albertini,
James M Mason,
James P Mcevoy,
Jason M Sluzynski,
Joan A Loreng,
Joan Adamo,
Joanne M Hajoway,
John D Jaworski,
Joseph George,
Joseph L Despins, PhD,
Joseph T Dougherty,
Joshua C Schafer,
Julianne C Mccullough,
Junho Pak,
Karyn M Campbell,
Katelyn Astaub Zamperini,
Kathleen B Mihalik,
Kathryn Carbone, MD,
Kelly N Kerr,
Kendra L Brooks,
Kenneth M Gordon,
Kimberly A Dux,
Kish Bolden,
Kristen D Evans,
Kristina J Donohue,
Kristina Mjoyce Pittman,
Kyle S Hobson,
Lauren E Swantko,
LCDR Susan E Polifko,
Linda M Hoover,
Linda Thai,
Lisa M Bellows,
Lisa M Feola,
LT John M Mastalski,
LT Mark A Chen, MPH,
LTJG Bradley E Benasutti,
Luis A Dasta,
Marcellinus D Dordunoo,
Margaret Faulkner,
Maria A Reed,
Marian E Major, PhD,
Martha Sullivan Myrick,
Matthew R Noonan,
Maureen A Wentzel,
Melissa M Dauksis,
Michael A Taylor,
Michael Curbarg,
Michael Gurbarg,
Michael J Nerz,
Michael L Casner,
Michele Gottshall,
Michele M Falchek,
Mihaly S Ligmond,
Myrick,
Nikisha M Bolden,
Oleg Vesnovsky,
Omotunde O Osunsanmi,
Paula A Trost,
Prabhu P Raju,
Qin Xu,
Ramon E Martinez,
Rebecca K Olin,
Richard C Cherry,
Richard J Bashay,
Robert B Shibuya, MD,
Robert D Tollefsen,
Ronald A Stokes,
Ronald T Colucci,
Rose Ashley,
Ruark Lanham,
Russell P Vandermark,
Sam Pepe,
Sarah Forney,
Scott E Norris,
Sean D Duke,
Sean Y Kassim, PhD,
Sheila Dreher Lesnick,
Shelley L Waring,
Shuang Tang,
Simone E Pitts,
Stephanie Mangigian, MS/OSH, RN,
Stephen D Brown,
Steven A Rubin,
Steven E Kane,
Susan F Laska, MS,
Tammy L Chavis,
Tammy M Phillips,
Thomas E Friel,
Tiffani D Wilson,
Timothy J Schmidt,
Tina S Roecklein,
Todd J Maushart,
Tonilynn Coiley,
Tonya O Corbin,
Travis R Hunt,
Van Cliff,
Vlada Matusovsky,
Wei Wang, PhD,
William A Warnick,
William C Brenneman,
Xiao Wang
LCDR Margaret Edi Gennaro's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more